Cost-utility analysis of timolol versus latanoprost versus travoprost in the treatment of glaucoma and ocular hypertension

被引：0
|
作者：
Lilliu, H
Le Pen, C
Berdeaux, G
机构：
[1] Alcon Labs Inc, Rueil Malmaison, France
[2] Clp Sante, Paris, France
来源：
VALUE IN HEALTH | 2002年 / 5卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)61457-X
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：552 / 553
页数：2
相关论文
共 50 条
  • [31] A Cost-Utility Analysis of Losartan versus Atenolol in the Treatment of Hypertension with Left Ventricular Hypertrophy
    Aslam H. Anis
    Huiying Sun
    Sonia Singh
    John Woolcott
    Bohdan Nosyk
    Marc Brisson
    PharmacoEconomics, 2006, 24 : 387 - 400
  • [32] Latanoprost in the treatment of glaucoma and ocular hypertension
    Watson, PG
    DRUGS OF TODAY, 1999, 35 (06) : 449 - 459
  • [33] Bimatoprost 0.03% versus travoprost 0.004% in Black Americans with glaucoma or ocular hypertension
    Robert J. Noecker
    Melissa L. Earl
    Tom Mundorf
    James Peace
    Robert D. Williams
    Advances in Therapy, 2003, 20 : 121 - 128
  • [34] Bimatoprost 0.03% versus travoprost 0.004% in black Americans with glaucoma ocular hypertension
    Noecker, RJ
    Earl, ML
    Mundorf, T
    Peace, J
    Williams, RD
    ADVANCES IN THERAPY, 2003, 20 (02) : 121 - 128
  • [35] Pharmacoeconomic analysis of latanoprost versus dorzolamide/timolol in the treatment of open-angle glaucoma in Spain
    Ortega, P
    Soto, J
    Fernandez-Arias, I
    De Miguel, V
    VALUE IN HEALTH, 2005, 8 (06) : A177 - A178
  • [36] Preserved Versus Preservative-Free Latanoprost for the Treatment of Glaucoma and Ocular Hypertension: A Post Hoc Pooled Analysis
    Paul Harasymowycz
    Cindy Hutnik
    Jean-François Rouland
    Francisco J. Muñoz Negrete
    Mario A. Economou
    Philippe Denis
    Christophe Baudouin
    Advances in Therapy, 2021, 38 : 3019 - 3031
  • [37] Efficiency of Travoprost versus Fixed-Combination Latanoprost/Timolol The Authors' Reply
    De Natale, Renato
    Lafuma, Antoine
    Berdeaux, Gilles
    CLINICAL DRUG INVESTIGATION, 2009, 29 (08) : 558 - 558
  • [38] Adherence to Fixed-Combination Versus Unfixed Travoprost 0.004%/Timolol 0.5% for Glaucoma. or Ocular Hypertension: A Randomized Trial
    Barnebey, Howard S.
    Robin, Alan L.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2017, 176 : 61 - 69
  • [39] Preserved Versus Preservative-Free Latanoprost for the Treatment of Glaucoma and Ocular Hypertension: A Post Hoc Pooled Analysis
    Harasymowycz, Paul
    Hutnik, Cindy
    Rouland, Jean-Francois
    Negrete, Francisco J. Munoz
    Economou, Mario A.
    Denis, Philippe
    Baudouin, Christophe
    ADVANCES IN THERAPY, 2021, 38 (06) : 3019 - 3031
  • [40] Effect of timolol, latanoprost, and dorzolamide on circadian IOP in glaucoma or ocular hypertension
    Orzalesi, N
    Rossetti, L
    Invernizzi, T
    Bottoli, A
    Autelitano, A
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2000, 41 (09) : 2566 - 2573
12345